Es. Kilpatrick et al., INCREASED FETAL HEMOGLOBIN IN INSULIN-TREATED DIABETES-MELLITUS CONTRIBUTES TO THE IMPRECISION OF GLYCOHEMOGLOBIN MEASUREMENTS, Clinical chemistry, 39(5), 1993, pp. 833-835
An increased prevalence of fetal hemoglobin (HbF) has been described i
n pediatric insulin-dependent patients. The popular electroendosmotic
method for glycohemoglobin includes HbF. In an adult population compri
sing 50 insulin-treated and 57 non-insulin-treated diabetic patients a
nd 57 control subjects, we measured HbF by HPLC and measured glycohemo
globin by both HPLC and an electroendosmotic method. Of the insulin-tr
eated patients, 46% had concentrations of HbF greater-than-or-equal-to
0.5%, compared with 25% of non-insulin-treated patients and 23% of co
ntrols (P <0.02). In the insulin-treated patients, the two glycohemogl
obin methods correlated best when the HPLC measurements included HbF (
r = 0.92 vs r = 0.84). Fructosamine concentrations correlated best wit
h glycohemoglobin concentrations determined by methods that accounted
for HbF. The true between-batch CV of the electroendosmotic assay incr
eased (from 4.33% to 8.33%) when variable interpatient HbF concentrati
ons were included. Thus, HbF must be considered when interpreting glyc
ohemoglobin measured by an electroendosmotic method and when comparing
it with other measures of glycemic control.